OneAscent Family Office »

Royalty Pharma shares owned by OneAscent Family Office

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by OneAscent Family Office from 13F filings

Historical chart of OneAscent Family Office investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by OneAscent Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by OneAscent Family Office

Quarter filed Position value Share count Share price at filing
2026-06-30 $203k 3.6k 56.07

More positions owned by OneAscent Family Office

Unified Ser Tr Oneascent Intl (OAIM)
Unified Ser Tr Onea Core Bd Etf (OACP)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Select Sector Spdr Tr St Str Energ Etf (XLE)
Ishares Tr Eafe Value Etf (EFV)
NVIDIA Corporation (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Unified Ser Tr Oneascent Emgrg (OAEM)
Vanguard Index Fds Extend Mkt Etf (VXF)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Unified Ser Tr Oneascent Large (OALC)
Broadcom (AVGO)
Amazon (AMZN)

View all positions for OneAscent Family Office

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
BlackRock
FMR
State Street Corporation
Swedbank AB
Baillie Gifford & Co
Geode Capital Management
Capital World Investors
Caledonia
Norges Bank Investment Management
Vanguard Capital Management
Northern Trust
Royal London Asset Management
AQR Capital Management

View all funds holding Royalty Pharma